Your browser doesn't support javascript.
loading
Implementation of Bedaquiline, Pretomanid, and Linezolid in the United States: Experience Using a Novel All-Oral Treatment Regimen for Treatment of Rifampin-Resistant or Rifampin-Intolerant Tuberculosis Disease.
Haley, Connie A; Schechter, Marcos C; Ashkin, David; Peloquin, Charles A; Peter Cegielski, J; Andrino, Barbara B; Burgos, Marcos; Caloia, Lori A; Chen, Lisa; Colon-Semidey, Angel; DeSilva, Malini B; Dhanireddy, Shireesha; Dorman, Susan E; Dworkin, Felicia F; Hammond-Epstein, Heidi; Easton, Alice V; Gaensbauer, James T; Ghassemieh, Bijan; Gomez, Maria E; Horne, David; Jasuja, Supriya; Jones, Betsy A; Kaplan, Leonard J; Khan, Asharaf Edward; Kracen, Elizabeth; Labuda, Sarah; Landers, Karen M; Lardizabal, Alfred A; Lasley, Maria T; Letzer, David M; Lopes, Vinicius K; Lubelchek, Ronald J; Patricia Macias, C; Mihalyov, Aimee; Misch, Elizabeth Ann; Murray, Jason A; Narita, Masahiro; Nilsen, Diana M; Ninneman, Megan J; Ogawa, Lynne; Oladele, Alawode; Overman, Melissa; Ray, Susan M; Ritger, Kathleen A; Rowlinson, Marie-Claire; Sabuwala, Nadya; Schiller, Thomas M; Schwartz, Lawrence E; Spitters, Christopher; Thomson, Douglas B.
Affiliation
  • Haley CA; Southeastern National Tuberculosis Center, Division of Infectious Diseases and Global Medicine, Department of Medicine in the College of Medicine, University of Florida, Gainesville, Florida, USA.
  • Schechter MC; Division of Infectious Diseases, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
  • Ashkin D; Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA.
  • Peloquin CA; Georgia State Tuberculosis Program, Atlanta, Georgia, USA.
  • Peter Cegielski J; Southeastern National Tuberculosis Center, Division of Infectious Diseases and Global Medicine, Department of Medicine in the College of Medicine, University of Florida, Gainesville, Florida, USA.
  • Andrino BB; Translational Research, College of Pharmacy and Emerging Pathogens Institute, University of Florida, Gainesville, Florida, USA.
  • Burgos M; Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, Georgia, USA.
  • Caloia LA; Fairfax County Health Department, Annandale, Virginia, USA.
  • Chen L; New Mexico Department of Health, Santa Fe, New Mexico, USA.
  • Colon-Semidey A; University of New Mexico School of Medicine, Albuquerque, New Mexico, USA.
  • DeSilva MB; New Mexico Veterans Affairs Health Care System, Albuquerque, New Mexico, USA.
  • Dhanireddy S; Louisville Metro Department of Public Health and Wellness, Louisville, Kentucky, USA.
  • Dorman SE; Humana Healthy Horizons in Kentucky, Louisville, Kentucky, USA.
  • Dworkin FF; Curry International Tuberculosis Center, University of California, San Francisco, California, USA.
  • Hammond-Epstein H; Puerto Rico Department of Health, San Juan, Puerto Rico, USA.
  • Easton AV; Saint Paul-Ramsey County Public Health, Saint Paul, Minnesota, USA.
  • Gaensbauer JT; HealthPartners Institute, Bloomington, Minnesota, USA.
  • Ghassemieh B; Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, Washington, USA.
  • Gomez ME; Department of Medicine, Medical University of South Carolina, Charleston, South Carolina, USA.
  • Horne D; South Carolina Department of Health and Environmental Control, Greenville, South Carolina, USA.
  • Jasuja S; New York City Department of Health and Mental Hygiene, Bureau of Tuberculosis Control, New York, New York, USA.
  • Jones BA; Southeastern National Tuberculosis Center, University of Florida, Gainesville, Florida, USA.
  • Kaplan LJ; New York City Department of Health and Mental Hygiene, Bureau of Tuberculosis Control, New York, New York, USA.
  • Khan AE; Department of Pediatrics and Adolescent Medicine, Mayo Clinic, Rochester, Minnesota, USA.
  • Kracen E; Public Health-Seattle & King County, Seattle, Washington, USA.
  • Labuda S; Department of Medicine, University of Washington, Seattle, Washington, USA.
  • Landers KM; Southeastern National Tuberculosis Center, University of Florida, Gainesville, Florida, USA.
  • Lardizabal AA; Pulmonary, Critical Care and Sleep Medicine, Harborview Medical Center, University of Washington, Seattle, Washington, USA.
  • Lasley MT; Cook County Department of Public Health, Forest Park, Illinois, USA.
  • Letzer DM; Bureau of Public Health Laboratories, Florida State Tuberculosis Program, Jacksonville, Florida, USA.
  • Lopes VK; Division of Infectious Diseases, Department of Medicine, NorthShore University HealthSystem, Evanston, Illinois, USA.
  • Lubelchek RJ; Jefferson County Department of Health, Birmingham, Alabama, USA.
  • Patricia Macias C; Public Health-Seattle & King County, Seattle, Washington, USA.
  • Mihalyov A; Department of Medicine, University of Washington, Seattle, Washington, USA.
  • Misch EA; Division of Tuberculosis Elimination, Centers for Disease Control and Prevention, Puerto Rico Department of Health, San Juan, Puerto Rico, USA.
  • Murray JA; Alabama Department of Public Health, Montgomery, Alabama, USA.
  • Narita M; Global Tuberculosis Institute, Rutgers University, Newark, New Jersey, USA.
  • Nilsen DM; Southeastern National Tuberculosis Center, University of Florida, Gainesville, Florida, USA.
  • Ninneman MJ; Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
  • Ogawa L; Sheboygan County Health and Human Services, Sheboygan, Wisconsin, USA.
  • Oladele A; Southern California Infectious Diseases Associates, Inc., Newport Beach, California, USA.
  • Overman M; Cook County Department of Public Health, Forest Park, Illinois, USA.
  • Ray SM; Division of Infectious Diseases, John H. Stroger, Jr. Hospital of Cook County, Chicago, Illinois, USA.
  • Ritger KA; Department of Medicine, Rush University Medical Center, Chicago, Illinois, USA.
  • Rowlinson MC; Health Transformation Program NorthShore University, Chicago, Illinois, USA.
  • Sabuwala N; The International Union Against Tuberculosis and Lung Disease, Paris, France.
  • Schiller TM; Louisville Metro Department of Public Health and Wellness, Louisville, Kentucky, USA.
  • Schwartz LE; Division of Infectious Disease, Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA.
  • Spitters C; Emergency Medicine, Saint Elizabeth Healthcare System, Edgewood, Kentucky, USA.
  • Thomson DB; Northern Kentucky Health Department, Florence, Kentucky, USA.
Clin Infect Dis ; 77(7): 1053-1062, 2023 10 05.
Article de En | MEDLINE | ID: mdl-37249079
Sujet(s)
Mots clés
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tuberculose / Tuberculose multirésistante Type d'étude: Guideline Limites: Humans Pays/Région comme sujet: America do norte Langue: En Journal: Clin Infect Dis Sujet du journal: DOENCAS TRANSMISSIVEIS Année: 2023 Type de document: Article Pays d'affiliation: États-Unis d'Amérique Pays de publication: États-Unis d'Amérique
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tuberculose / Tuberculose multirésistante Type d'étude: Guideline Limites: Humans Pays/Région comme sujet: America do norte Langue: En Journal: Clin Infect Dis Sujet du journal: DOENCAS TRANSMISSIVEIS Année: 2023 Type de document: Article Pays d'affiliation: États-Unis d'Amérique Pays de publication: États-Unis d'Amérique